Sun Pharmaceutical Industries Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is TOFACITINIB CITRATE, with a corresponding US DMF Number 30617.
Remarkably, this DMF maintains an Active status since its submission on August 02, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 28, 2016, and payment made on July 14, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II